Structural Optimization of Bicyclic Oxo-Boronates as Dual Metallo- and Serine-β-Lactamase Inhibitors
Journal of Medicinal Chemistry · 23.10.2025 · 68 (20) · 21807-21828
DOI: 10.1021/acs.jmedchem.5c02230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 13.10.2025. Verfasst von Zeng-Bao Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Department of Medicinal Chemistry, West Chi…. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, Boronic Acids, beta-Lactamases, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Gram-negative bacterial resistance to β-lactam antibiotics is a growing clinical problem, largely driven by the production of metallo-β-lactamases (MBLs) and serine-β-lactamases (SBLs). Developing dual inhibitors targeting both MBLs and SBLs has emerged as a focus in the fight against β-lactam resistance. We previously identified the bicyclic oxo-boronate CB1 as a dual MBL/SBL inhibitor through molecular generation based on the binding mode of carbapenem tetrahedral intermediates. Herein, we report the structural optimization of CB1, yielding new bicyclic oxo-boronates with potent dual MBL/SBL inhibition, some of which could potentiate Meropenem efficacy against carbapenem-resistant Gram-negative superbugs. X-ray crystallography revealed a common binding mode of bicyclic oxo-boronates with VIM-2/NDM-1 MBL and OXA-48 SBL, mimicking the binding of carbapenem intermediates. YL6113 exhibited pharmacokinetic characteristics similar to Meropenem and manifested efficacy when combined with Meropenem in a murine sepsis model. This work provides the basis for developing oxo-boronate-based inhibitors targeting MBLs/SBLs and other relevant targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Department of Medicinal Chemistry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
- Children's Medicine Key Laboratory of Sichuan Province, Sichuan University, Chengdu, Sichuan 610041, China.
ORCID-Profile: Zeng-Bao Yang, Si-Qi Wei, Yao-Geng Wang, Hao-Xiang Xu, Xiao-Lan Li, Guo-Bo Li
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
- Basic Research Foundation of Sichuan University
Zitieren
APA
Yang, Z. B., Wei, S. Q., Wang, Y. G., Dong, X. M., Xu, H. X., Li, X. L., Peng, J., Yin, R. C., & Li, G. B. (2025). Structural Optimization of Bicyclic Oxo-Boronates as Dual Metallo- and Serine-β-Lactamase Inhibitors. Journal of Medicinal Chemistry, 68(20), 21807-21828. https://doi.org/10.1021/acs.jmedchem.5c02230
Vancouver
Yang ZB, Wei SQ, Wang YG, Dong XM, Xu HX, Li XL, et al. Structural Optimization of Bicyclic Oxo-Boronates as Dual Metallo- and Serine-β-Lactamase Inhibitors. Journal of Medicinal Chemistry. 2025;68(20):21807-21828. doi:10.1021/acs.jmedchem.5c02230
BibTeX
@article{Yang2025,
author = {Yang, Zeng-Bao and Wei, Si-Qi and Wang, Yao-Geng and Dong, Xiang-Min and Xu, Hao-Xiang and Li, Xiao-Lan and Peng, Jian and Yin, Rui-Chuan and Li, Guo-Bo},
title = {Structural Optimization of Bicyclic Oxo-Boronates as Dual Metallo- and Serine-β-Lactamase Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {20},
pages = {21807--21828},
doi = {10.1021/acs.jmedchem.5c02230}
}
EUVIMED